Investors Alleging $51M Loss To Lead Pharma Co. Suit
By Sydney Price · October 11, 2023, 7:50 PM EDT
A New York judge on Wednesday appointed two institutional investors to lead a proposed shareholder action alleging biopharma company Syneos Health lied about its booming business during the COVID-19 pandemic, saying...
To view the full article, register now.